CPG
COLL icon

Cornerstone Planning Group’s Collegium Pharmaceutical COLL Stock Holding History

Cornerstone Planning Group’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-15
Closed -$509 – 1586
2024
Q4 		$509 Buy
+15
New +$496 ﹤0.01% 1129

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cornerstone Planning Group's COLL Position: Q1 2025 in Review

Cornerstone Planning Group sold out of Collegium Pharmaceutical (COLL) in Q1 2025, closing a stake of 15 shares — an estimated $509 sold.

Cornerstone Planning Group first reported a position in COLL in Q4 2024 and held it in 1 quarter. The position peaked at $509 in Q4 2024. 242 funds tracked by Wall St. Rank hold COLL as of Q1 2025.

  • Cornerstone Planning Group reported no remaining Collegium Pharmaceutical position as of Q1 2025 after selling out during the quarter.
  • Cornerstone Planning Group sold 15 Collegium Pharmaceutical shares in Q1 2025, an estimated $509.
  • Cornerstone Planning Group first reported a position in Collegium Pharmaceutical in Q4 2024 and held it in 1 quarter.
  • Cornerstone Planning Group's Collegium Pharmaceutical position peaked at $509 in Q4 2024.
  • 242 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2025.

Based on Cornerstone Planning Group's 13F filing for Q1 2025, filed 30 Apr 2025.